China's CSPC Pharma collaborates with Pfizer for Oral COVID Treatment

To increase treatment accessibility in China, the Chinese pharmaceutical company CSPC Pharmaceutical Group said later this week that it has partnered with Pfizer in a strategic alliance to introduce a local brand of an oral COVID-19 therapy...

Challenges Faced in Manufacturing Active Pharmaceutical Ingredients

Manufacturing of Active Pharmaceutical Ingredients (APIs) is a critical step in the productionof pharmaceutical drugs.

Lupin Achieves a Major Milestone for its Phase 1 Clinical Stage MALT1 Inhibitor Programme

Lupin Limited announced the achievement of a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor programme, which is being developed in collaboration with AbbVie Inc. to treat a variety...

Corona Buys Myoril Brand from Sanofi Healthcare India for Rs 234 crore

Corona Remedies Pvt Ltd, based in the city, has announced the acquisition of the Myoril brand from global pharmaceutical giant Sanofi for Rs 234 crore. The Myoril brand will be acquired for the Indian market on June 28, 2023...

US FDA Granted Approval to Pfizer-OPKO's Drug for Growth Hormone Deficiency in Kids

The US FDA has authorized Pfizer Inc and partner OPKO Health Inc's medication for growth hormone insufficiency in children, the firms announced this week. The drug's clearance, which comes after an initial rejection by the FDA in January...

iNova to Acquire Mundipharma's Consumer Healthcare Brands for $540 mln

Singapore-headquartered iNova Pharmaceuticals will buy a portfolio of consumer healthcare brands from Sackler-owned Mundipharma International for an enterprise value of $540 million, an iNova spokesperson said earlier this week....

Govt Interventions Like R&D Grants Needed To Boost Manufacturing Antigen Test Kits: Expert

According to Manav Teli, executive director of Lord's Mark Industries, government interventions such as streamlining regulatory processes, offering research and development grants, and facilitating partnerships between manufacturers...

DCGI authorised Akums Perampanel oral Suspension for Treatment of Epilepsy

Akums announced the approval of perampanel oral suspension by the Drug Controller General of India (DCGI). The perampanel oral suspension is a bioequivalent formulation to the US FDA-approved FYCOMPA (perampanel) oral suspension...

RYSTIGGO Receives U.S FDA Approval

The U.S. Food and Drug Administration has approved RYSTIGGO for the treatment of generalised myasthenia gravis in adult patients who have anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positivity, according to UCB...

COSBI Announce Strategic Partnership with InSilicoTrials To transform Drug Development and Regulatory Approval

InSilicoTrials, a top supplier of artificial intelligence (AI) and simulation tools for drug and medical device development, and COSBI, a premier systems biology research centre, have forged a ground-breaking strategic partnership with the aim of...

© 2024 India Pharma Outlook. All Rights Reserved.